Arsenic Poisoning Clinical Trial
— SHWSOfficial title:
Participatory Interventions to Reduce Arsenic Exposure in American Indian Communities
Verified date | June 2024 |
Source | Johns Hopkins Bloomberg School of Public Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Develop and evaluate the effectiveness of multi-level participatory interventions in reducing arsenic exposure among American Indian (AI) communities from North and South Dakota who participated in the Strong Heart Study (SHS).
Status | Active, not recruiting |
Enrollment | 57 |
Est. completion date | May 4, 2025 |
Est. primary completion date | May 4, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 10 Years and older |
Eligibility | Inclusion Criteria: - Arsenic levels in household drinking water must be =10 µg/L - Households must have =1 adult =18 years of age eligible and willing to participate. - Household must have an active well on the property that is used for drinking water. - Household must have indoor plumbing and a permanent heat source. - Participant must plan to reside in the household for the next year, must reside in the residence for =4 days/week, and year round (i.e. all seasons). - =1 household members must identify as American Indian. - Household must be willing to grant study members access to the interior of their household for screening and data collection. Exclusion Criteria: - Arsenic levels in household drinking water <10 µg/L - Households with no adult =18 years of age eligible and willing to participate. - Households without an active well on the property that is used for drinking water (i.e. connected to municipal water supply). - Households without indoor plumbing and/or a permanent heat source. - Participant planning to reside in the household <1 year, residing in the residence for <4 days/week, or not year round (i.e. not during all seasons). - No household member identifies as American Indian. - Household unwilling to grant study members access to the interior of their household for screening and data collection. |
Country | Name | City | State |
---|---|---|---|
United States | Johns Hopkins Bloomberg School of Public Health, ICTR | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
Johns Hopkins Bloomberg School of Public Health | Columbia University, Missouri Breaks Industries Research, Inc., National Institute Of Allergy & Infectuous Disease |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Urine arsenic concentrations in household members | (1a) urine arsenic concentrations among household members (in parts per billion, µg/L) | 6 months post-installation of the arsenic removal device | |
Secondary | Arsenic concentrations in filtered water | (2a) water arsenic concentrations from arsenic removal device (parts per billion, µg/L) | 6 months post-installation of the arsenic removal device | |
Secondary | Water usage from arsenic removal device | (2b) water usage from removal device (from flow meter, in gallons) | 6 months post-installation of the arsenic removal device | |
Secondary | Biomarkers of cardiovascular disease | (2c) biomarkers of cardiovascular disease (soluble adhesion molecules) in household members | 6 months post-installation of the arsenic removal device | |
Secondary | Biomarkers of diabetes | (2d) biomarkers of diabetes (hemoglobin A1c) in household members | 6 months post-installation of the arsenic removal device | |
Secondary | Biomarkers of pulmonary function | (2e.1) lower forced expiratory volume in 1 second (FEV1) (actual performance in liters of air, percent of predicted values) | 6 months post-installation of the arsenic removal device | |
Secondary | Biomarkers of pulmonary function | (2e.2) lower forced vital capacity (FVC) among household members (actual performance in liters of air, percent of predicted values) | 6 months post-installation of the arsenic removal device | |
Secondary | Blood pressure | (2f) systolic and diastolic blood pressure levels | 6 months post-installation of the arsenic removal device | |
Secondary | Long-term urine arsenic concentrations in household members | (2g) long-term sustainability assessment to evaluate arsenic concentrations in urine among household members (parts per billion, µg/L) | 1 year post-installation of the arsenic removal device | |
Secondary | Long-term functionality of arsenic removal device | (2h) long-term sustainability assessment to evaluate water arsenic concentrations from arsenic removal device (parts per billion, µg/L) | 1 year post-installation of the arsenic removal device | |
Secondary | Long-term water usage from arsenic removal device | (2i) long-term sustainability assessment to evaluate water usage from removal device (from flow meter, in gallons) | 1 year post-installation of the arsenic removal device | |
Secondary | Long-term maintenance of arsenic removal device | (2j) long-term sustainability assessment to evaluate self-reported maintenance of the arsenic removal device (Did household change the device filter when indicated by light on spigot? Does household have replacement filter(s) available for subsequent filter change(s)?) | 1 year post-installation of the arsenic removal device |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02429921 -
High-selenium Lentils Versus Arsenic Toxicity
|
N/A | |
Active, not recruiting |
NCT02235948 -
Effects of Folic Acid Supplementation on Arsenic Lowering
|
Phase 2 | |
Completed |
NCT01442727 -
Selenium in the Treatment of Arsenic Toxicity and Cancers
|
Phase 3 |